Publication: ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer
Program
KU-Authors
KU Authors
Co-Authors
Lorusso, D.
Xiang, Y.
Colombo, N.
Coleman, R.
Randall, L.
Duska, L.
Hasegawa, K.
Nogueira-Rodrigues, A.
Cibula, D.
Mirza, M. R.
Publication Date
Language
Type
Embargo Status
No
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Source
Publisher
Elsevier
Subject
Oncology
Citation
Has Part
Source
Annals of Oncology
ESMO Asia Virtual Congress
ESMO Asia Virtual Congress
Book Series Title
Edition
DOI
10.1016/j.annonc.2020.10.248
item.page.datauri
Link
Rights
Copyrighted